What is the definition of malignant hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Malignant hypertension is defined as a severe BP elevation (usually >200/120 mmHg) and advanced retinopathy, characterized by the bilateral presence of flame-shaped haemorrhages, cotton wool spots, or papilloedema, as outlined in the 2019 esc council on hypertension position document 1.

Definition and Characteristics

Malignant hypertension is a hypertensive emergency that requires immediate attention to prevent further organ damage. The condition is marked by extremely high blood pressure readings, often exceeding 200/120 mmHg, accompanied by signs of advanced retinopathy, including flame-shaped haemorrhages, cotton wool spots, or papilloedema. This definition is supported by the most recent guidelines, including the 2024 esc guidelines for the management of elevated blood pressure and hypertension 1.

Key Features

The key features of malignant hypertension include:

  • Severe BP elevation (usually >200/120 mmHg)
  • Advanced retinopathy, characterized by:
    • Flame-shaped haemorrhages
    • Cotton wool spots
    • Papilloedema
  • Potential for acute end-organ damage, including:
    • Encephalopathy
    • Acute kidney injury
    • Heart failure
    • Retinal hemorrhages and exudates

Management

The management of malignant hypertension involves immediate hospitalization and intravenous antihypertensive therapy to gradually lower blood pressure. The goal is to reduce blood pressure by no more than 25% within the first hour, then to 160/100-110 mmHg within the next 2-6 hours, and to normal levels over the following days. This careful approach prevents complications from too-rapid blood pressure reduction, as recommended by the 2024 esc guidelines 1.

From the Research

Definition of Malignant Hypertension

  • Malignant hypertension is defined as a severe form of hypertension characterized by extreme blood pressure elevation and acute microvascular damage affecting various organs, particularly the retinas, brain, and kidneys 2.
  • It requires the presence of bilateral retinal hemorrhages or exudates, with or without papilledema, acute heart failure, and acute deterioration in renal function in severe hypertension 3.
  • The condition is also defined by high blood pressure and acute ischemic organ damage, with a worse prognosis than other forms of hypertension, especially in black patients 4.

Diagnostic Criteria

  • The diagnosis of malignant hypertension is usually based on the association of severely elevated blood pressure with a Keith and Wagener stage III or IV retinopathy 5.
  • However, it has been proposed that the definition of malignant hypertension should be reconsidered to include acute hypertension with multi-organ damage (hypertension-MOD), which is characterized by acute elevation of blood pressure associated with impairment of at least three different target organs 5.
  • The diagnostic criteria may also include the presence of target organ damage, such as pulmonary edema/heart failure, acute coronary syndrome, ischemic and hemorrhagic stroke 6.

Characteristics

  • Malignant hypertension is a systemic disease that causes severe damage to the brain, heart, kidneys, and eyes, even in the absence of symptoms 4.
  • Patients with malignant hypertension are characterized by pronounced target organ damage, including structural and functional cardiac abnormalities and renal insufficiency 3.
  • The condition has a high prevalence of left ventricular mass, systolic dysfunction, renal involvement, and thrombotic microangiopathy 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.